Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function

High-dose methotrexate (MTX; ≥1 g/m(2)) is a renally eliminated and nephrotoxic first-line therapy for central nervous system (CNS) lymphoma. Creatinine-based estimation of renal function is the recommended approach to dosing MTX in these cases, but nonrenal determinants of creatinine production and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Case Rep Hematol
Egile Nagusiak: Barreto, Jason N., McClanahan, Allison L., Rule, Andrew D., Thompson, Carrie A., Frazee, Erin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2018
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892267/
https://ncbi.nlm.nih.gov/pubmed/29780646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7169897
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak